{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T18:15:08Z","timestamp":1790878508411,"version":"4.1.0"},"reference-count":76,"publisher":"Rockefeller University Press","issue":"12","license":[{"start":{"date-parts":[[2023,9,29]],"date-time":"2023-09-29T00:00:00Z","timestamp":1695945600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100010661","name":"European Research Council under the Europan Union's Horizon 2020 research and innovation programme","doi-asserted-by":"publisher","award":["818806"],"award-info":[{"award-number":["818806"]}],"id":[{"id":"10.13039\/100010661","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100008483","name":"NOMIS Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100008483","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100018246","name":"Lotte and Adolf Hotz-Sprenger Stiftung","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100018246","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001711","name":"Schweizerischer Nationalfonds zur F\u00f6rderung der Wissenschaftlichen Forschung","doi-asserted-by":"publisher","award":["310030_188858"],"award-info":[{"award-number":["310030_188858"]}],"id":[{"id":"10.13039\/501100001711","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100005237","name":"Helen Hay Whitney Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100005237","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002347","name":"Bundesministerium f\u00fcr Bildung und Forschung","doi-asserted-by":"publisher","award":["FKZ 01ZZ2015"],"award-info":[{"award-number":["FKZ 01ZZ2015"]}],"id":[{"id":"10.13039\/501100002347","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["rupress.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2023,12,4]]},"abstract":"<jats:p>Targeted eradication of transformed or otherwise dysregulated cells using monoclonal antibodies (mAb), antibody\u2013drug conjugates (ADC), T cell engagers (TCE), or chimeric antigen receptor (CAR) cells is very effective for hematologic diseases. Unlike the breakthrough progress achieved for B cell malignancies, there is a pressing need to find suitable antigens for myeloid malignancies. CD123, the interleukin-3 (IL-3) receptor alpha-chain, is highly expressed in various hematological malignancies, including acute myeloid leukemia (AML). However, shared CD123 expression on healthy hematopoietic stem and progenitor cells (HSPCs) bears the risk for myelotoxicity. We demonstrate that epitope-engineered HSPCs were shielded from CD123-targeted immunotherapy but remained functional, while CD123-deficient HSPCs displayed a competitive disadvantage. Transplantation of genome-edited HSPCs could enable tumor-selective targeted immunotherapy while rebuilding a fully functional hematopoietic system. We envision that this approach is broadly applicable to other targets and cells, could render hitherto undruggable targets accessible to immunotherapy, and will allow continued posttransplant therapy, for instance, to treat minimal residual disease (MRD).<\/jats:p>","DOI":"10.1084\/jem.20231235","type":"journal-article","created":{"date-parts":[[2023,9,9]],"date-time":"2023-09-09T02:20:55Z","timestamp":1694226055000},"update-policy":"https:\/\/doi.org\/10.1084\/jem.crossmarkpolicy","source":"Crossref","is-referenced-by-count":42,"title":["Epitope-engineered human hematopoietic stem cells are shielded from CD123-targeted immunotherapy"],"prefix":"10.1084","volume":"220","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-1474-1689","authenticated-orcid":true,"given":"Romina","family":"Marone","sequence":"first","affiliation":[{"id":[{"id":"https:\/\/ror.org\/02s6k3f65","id-type":"ROR","asserted-by":"publisher"}],"name":"Basel University Hospital and University of Basel 1 Department of Biomedicine, , Basel, Switzerland"},{"id":[{"id":"https:\/\/ror.org\/04k51q396","id-type":"ROR","asserted-by":"publisher"}],"name":"Basel University Hospital 2 Transplantation Immunology and Nephrology, , Basel, Switzerland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6993-1434","authenticated-orcid":true,"given":"Emmanuelle","family":"Landmann","sequence":"additional","affiliation":[{"id":[{"id":"https:\/\/ror.org\/02s6k3f65","id-type":"ROR","asserted-by":"publisher"}],"name":"Basel University Hospital and University of Basel 1 Department of Biomedicine, , Basel, Switzerland"},{"id":[{"id":"https:\/\/ror.org\/04k51q396","id-type":"ROR","asserted-by":"publisher"}],"name":"Basel University Hospital 2 Transplantation Immunology and Nephrology, , Basel, Switzerland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5114-9337","authenticated-orcid":true,"given":"Anna","family":"Devaux","sequence":"additional","affiliation":[{"id":[{"id":"https:\/\/ror.org\/02s6k3f65","id-type":"ROR","asserted-by":"publisher"}],"name":"Basel University Hospital and University of Basel 1 Department of Biomedicine, , Basel, Switzerland"},{"id":[{"id":"https:\/\/ror.org\/04k51q396","id-type":"ROR","asserted-by":"publisher"}],"name":"Basel University Hospital 2 Transplantation Immunology and Nephrology, , Basel, Switzerland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9481-2557","authenticated-orcid":true,"given":"Rosalba","family":"Lepore","sequence":"additional","affiliation":[{"id":[{"id":"https:\/\/ror.org\/02s6k3f65","id-type":"ROR","asserted-by":"publisher"}],"name":"Basel University Hospital and University of Basel 1 Department of Biomedicine, , Basel, Switzerland"},{"id":[{"id":"https:\/\/ror.org\/04k51q396","id-type":"ROR","asserted-by":"publisher"}],"name":"Basel University Hospital 2 Transplantation Immunology and Nephrology, , Basel, Switzerland"},{"name":"Cimeio Therapeutics AG 3 , Basel, Switzerland"},{"name":"Ridgeline Discovery GmbH 4 , Basel, Switzerland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2066-6980","authenticated-orcid":true,"given":"Denis","family":"Seyres","sequence":"additional","affiliation":[{"id":[{"id":"https:\/\/ror.org\/02s6k3f65","id-type":"ROR","asserted-by":"publisher"}],"name":"Basel University Hospital and University of Basel 1 Department of Biomedicine, , Basel, Switzerland"},{"id":[{"id":"https:\/\/ror.org\/04k51q396","id-type":"ROR","asserted-by":"publisher"}],"name":"Basel University Hospital 2 Transplantation Immunology and Nephrology, , Basel, Switzerland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3253-1984","authenticated-orcid":true,"given":"Jessica","family":"Zuin","sequence":"additional","affiliation":[{"id":[{"id":"https:\/\/ror.org\/02s6k3f65","id-type":"ROR","asserted-by":"publisher"}],"name":"Basel University Hospital and University of Basel 1 Department of Biomedicine, , Basel, Switzerland"},{"id":[{"id":"https:\/\/ror.org\/04k51q396","id-type":"ROR","asserted-by":"publisher"}],"name":"Basel University Hospital 2 Transplantation Immunology and Nephrology, , Basel, Switzerland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0006-8324-8934","authenticated-orcid":true,"given":"Thomas","family":"Burgold","sequence":"additional","affiliation":[{"id":[{"id":"https:\/\/ror.org\/02s6k3f65","id-type":"ROR","asserted-by":"publisher"}],"name":"Basel University Hospital and University of Basel 1 Department of Biomedicine, , Basel, Switzerland"},{"id":[{"id":"https:\/\/ror.org\/04k51q396","id-type":"ROR","asserted-by":"publisher"}],"name":"Basel University Hospital 2 Transplantation Immunology and Nephrology, , Basel, Switzerland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0007-9796-4277","authenticated-orcid":true,"given":"Corinne","family":"Engdahl","sequence":"additional","affiliation":[{"id":[{"id":"https:\/\/ror.org\/02s6k3f65","id-type":"ROR","asserted-by":"publisher"}],"name":"Basel University Hospital and University of Basel 1 Department of Biomedicine, , Basel, Switzerland"},{"id":[{"id":"https:\/\/ror.org\/04k51q396","id-type":"ROR","asserted-by":"publisher"}],"name":"Basel University Hospital 2 Transplantation Immunology and Nephrology, , Basel, Switzerland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0001-6459-2864","authenticated-orcid":true,"given":"Giuseppina","family":"Capoferri","sequence":"additional","affiliation":[{"id":[{"id":"https:\/\/ror.org\/02s6k3f65","id-type":"ROR","asserted-by":"publisher"}],"name":"Basel University Hospital and University of Basel 1 Department of Biomedicine, , Basel, Switzerland"},{"id":[{"id":"https:\/\/ror.org\/04k51q396","id-type":"ROR","asserted-by":"publisher"}],"name":"Basel University Hospital 2 Transplantation Immunology and Nephrology, , Basel, Switzerland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0006-9918-3063","authenticated-orcid":true,"given":"Alessandro","family":"Dell\u2019Aglio","sequence":"additional","affiliation":[{"id":[{"id":"https:\/\/ror.org\/02s6k3f65","id-type":"ROR","asserted-by":"publisher"}],"name":"Basel University Hospital and University of Basel 1 Department of Biomedicine, , Basel, Switzerland"},{"id":[{"id":"https:\/\/ror.org\/04k51q396","id-type":"ROR","asserted-by":"publisher"}],"name":"Basel University Hospital 2 Transplantation Immunology and Nephrology, , Basel, Switzerland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5827-8433","authenticated-orcid":true,"given":"Cl\u00e9ment","family":"Larrue","sequence":"additional","affiliation":[{"id":[{"id":"https:\/\/ror.org\/01swzsf04","id-type":"ROR","asserted-by":"publisher"}],"name":"University of Geneva, and Swiss Cancer Center Leman 5 Translational Research Centre in Onco-Hematology, Faculty of Medicine, , Geneva, Switzerland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0399-689X","authenticated-orcid":true,"given":"Federico","family":"Simonetta","sequence":"additional","affiliation":[{"name":"Geneva University Hospitals 6 Division of Hematology, Department of Oncology, , Geneva, Switzerland"},{"id":[{"id":"https:\/\/ror.org\/01swzsf04","id-type":"ROR","asserted-by":"publisher"}],"name":"University of Geneva 7 Department of Medicine, Translational Research Center for Onco-Hematology, Faculty of Medicine, , Geneva, Switzerland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0009-3023-3044","authenticated-orcid":true,"given":"Julia","family":"Rositzka","sequence":"additional","affiliation":[{"id":[{"id":"https:\/\/ror.org\/0245cg223","id-type":"ROR","asserted-by":"publisher"}],"name":"Institute for Transfusion Medicine and Gene Therapy, Medical Center - University of Freiburg 8 , Freiburg, Germany"},{"id":[{"id":"https:\/\/ror.org\/0245cg223","id-type":"ROR","asserted-by":"publisher"}],"name":"University of Freiburg 9 Center for Chronic Immunodeficiency, Faculty of Medicine, , Freiburg, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0741-2780","authenticated-orcid":true,"given":"Manuel","family":"Rhiel","sequence":"additional","affiliation":[{"id":[{"id":"https:\/\/ror.org\/0245cg223","id-type":"ROR","asserted-by":"publisher"}],"name":"Institute for Transfusion Medicine and Gene Therapy, Medical Center - University of Freiburg 8 , Freiburg, Germany"},{"id":[{"id":"https:\/\/ror.org\/0245cg223","id-type":"ROR","asserted-by":"publisher"}],"name":"University of Freiburg 9 Center for Chronic Immunodeficiency, Faculty of Medicine, , Freiburg, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5389-9481","authenticated-orcid":true,"given":"Geoffroy","family":"Andrieux","sequence":"additional","affiliation":[{"id":[{"id":"https:\/\/ror.org\/0245cg223","id-type":"ROR","asserted-by":"publisher"}],"name":"Institute of Medical Bioinformatics and Systems Medicine, Medical Center-University of Freiburg 10 , Freiburg, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5832-652X","authenticated-orcid":true,"given":"Danielle N.","family":"Gallagher","sequence":"additional","affiliation":[{"id":[{"id":"https:\/\/ror.org\/05a28rw58","id-type":"ROR","asserted-by":"publisher"}],"name":"Institute of Molecular Health Sciences, ETH Z\u00fcrich 11 Department of Biology, , Z\u00fcrich, Switzerland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5942-1254","authenticated-orcid":true,"given":"Markus S.","family":"Schr\u00f6der","sequence":"additional","affiliation":[{"id":[{"id":"https:\/\/ror.org\/05a28rw58","id-type":"ROR","asserted-by":"publisher"}],"name":"Institute of Molecular Health Sciences, ETH Z\u00fcrich 11 Department of Biology, , Z\u00fcrich, Switzerland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0003-2904-2407","authenticated-orcid":true,"given":"Am\u00e9lie","family":"Wiederkehr","sequence":"additional","affiliation":[{"name":"Ridgeline Discovery GmbH 4 , Basel, Switzerland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0009-2484-3495","authenticated-orcid":true,"given":"Alessandro","family":"Sinopoli","sequence":"additional","affiliation":[{"name":"Ridgeline Discovery GmbH 4 , Basel, Switzerland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0006-3836-627X","authenticated-orcid":true,"given":"Valentin","family":"Do Sacramento","sequence":"additional","affiliation":[{"name":"Cimeio Therapeutics AG 3 , Basel, Switzerland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3125-0152","authenticated-orcid":true,"given":"Anna","family":"Haydn","sequence":"additional","affiliation":[{"name":"Ridgeline Discovery GmbH 4 , Basel, Switzerland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3786-4852","authenticated-orcid":true,"given":"Laura","family":"Garcia-Prat","sequence":"additional","affiliation":[{"name":"Cimeio Therapeutics AG 3 , Basel, Switzerland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0001-9019-2602","authenticated-orcid":true,"given":"Christopher","family":"Divsalar","sequence":"additional","affiliation":[{"name":"Ridgeline Discovery GmbH 4 , Basel, Switzerland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2356-5242","authenticated-orcid":true,"given":"Anna","family":"Camus","sequence":"additional","affiliation":[{"name":"Cimeio Therapeutics AG 3 , Basel, Switzerland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7986-5928","authenticated-orcid":true,"given":"Liwen","family":"Xu","sequence":"additional","affiliation":[{"name":"School of Medicine, Stanford University 12 Department of Pediatrics, , Stanford, CA, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0875-1813","authenticated-orcid":true,"given":"Lorenza","family":"Bordoli","sequence":"additional","affiliation":[{"id":[{"id":"https:\/\/ror.org\/02s6k3f65","id-type":"ROR","asserted-by":"publisher"}],"name":"Biozentrum, University of Basel 13 , Basel, Switzerland"},{"name":"SIB Swiss Institute of Bioinformatics 14 , Basel, Switzerland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2715-335X","authenticated-orcid":true,"given":"Torsten","family":"Schwede","sequence":"additional","affiliation":[{"id":[{"id":"https:\/\/ror.org\/02s6k3f65","id-type":"ROR","asserted-by":"publisher"}],"name":"Biozentrum, University of Basel 13 , Basel, Switzerland"},{"name":"SIB Swiss Institute of Bioinformatics 14 , Basel, Switzerland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3850-4648","authenticated-orcid":true,"given":"Matthew","family":"Porteus","sequence":"additional","affiliation":[{"name":"School of Medicine, Stanford University 12 Department of Pediatrics, , Stanford, CA, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0167-5996","authenticated-orcid":true,"given":"J\u00e9r\u00f4me","family":"Tamburini","sequence":"additional","affiliation":[{"id":[{"id":"https:\/\/ror.org\/01swzsf04","id-type":"ROR","asserted-by":"publisher"}],"name":"University of Geneva 7 Department of Medicine, Translational Research Center for Onco-Hematology, Faculty of Medicine, , Geneva, Switzerland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7798-5309","authenticated-orcid":true,"given":"Jacob E.","family":"Corn","sequence":"additional","affiliation":[{"id":[{"id":"https:\/\/ror.org\/05a28rw58","id-type":"ROR","asserted-by":"publisher"}],"name":"Institute of Molecular Health Sciences, ETH Z\u00fcrich 11 Department of Biology, , Z\u00fcrich, Switzerland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7757-4630","authenticated-orcid":true,"given":"Toni","family":"Cathomen","sequence":"additional","affiliation":[{"id":[{"id":"https:\/\/ror.org\/0245cg223","id-type":"ROR","asserted-by":"publisher"}],"name":"Institute for Transfusion Medicine and Gene Therapy, Medical Center - University of Freiburg 8 , Freiburg, Germany"},{"id":[{"id":"https:\/\/ror.org\/0245cg223","id-type":"ROR","asserted-by":"publisher"}],"name":"University of Freiburg 9 Center for Chronic Immunodeficiency, Faculty of Medicine, , Freiburg, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7206-7541","authenticated-orcid":true,"given":"Tatjana I.","family":"Cornu","sequence":"additional","affiliation":[{"id":[{"id":"https:\/\/ror.org\/0245cg223","id-type":"ROR","asserted-by":"publisher"}],"name":"Institute for Transfusion Medicine and Gene Therapy, Medical Center - University of Freiburg 8 , Freiburg, Germany"},{"id":[{"id":"https:\/\/ror.org\/0245cg223","id-type":"ROR","asserted-by":"publisher"}],"name":"University of Freiburg 9 Center for Chronic Immunodeficiency, Faculty of Medicine, , Freiburg, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0009-9965-1658","authenticated-orcid":true,"given":"Stefanie","family":"Urlinger","sequence":"additional","affiliation":[{"name":"Cimeio Therapeutics AG 3 , Basel, Switzerland"},{"name":"Ridgeline Discovery GmbH 4 , Basel, Switzerland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3359-8796","authenticated-orcid":true,"given":"Lukas T.","family":"Jeker","sequence":"additional","affiliation":[{"id":[{"id":"https:\/\/ror.org\/02s6k3f65","id-type":"ROR","asserted-by":"publisher"}],"name":"Basel University Hospital and University of Basel 1 Department of Biomedicine, , Basel, Switzerland"},{"id":[{"id":"https:\/\/ror.org\/04k51q396","id-type":"ROR","asserted-by":"publisher"}],"name":"Basel University Hospital 2 Transplantation Immunology and Nephrology, , Basel, Switzerland"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"291","published-online":{"date-parts":[[2023,9,29]]},"reference":[{"key":"2023092913413966900_bib1","doi-asserted-by":"publisher","first-page":"824","DOI":"10.1038\/s41587-020-0561-9","article-title":"Genome editing with CRISPR-Cas nucleases, base editors, transposases and prime editors","volume":"38","author":"Anzalone","year":"2020","journal-title":"Nat. Biotechnol."},{"key":"2023092913413966900_bib2","doi-asserted-by":"publisher","first-page":"1181","DOI":"10.1016\/j.ymthe.2018.03.003","article-title":"Myeloid conditioning with c-kit-Targeted CAR-T cells enables donor stem cell engraftment","volume":"26","author":"Arai","year":"2018","journal-title":"Mol. Ther."},{"key":"2023092913413966900_bib3","doi-asserted-by":"publisher","DOI":"10.1126\/sciimmunol.abl4348","article-title":"X-linked recessive TLR7 deficiency in \u223c1% of men under 60 years old with life-threatening COVID-19","volume":"6","author":"Asano","year":"2021","journal-title":"Sci. Immunol."},{"key":"2023092913413966900_bib4","doi-asserted-by":"publisher","first-page":"1473","DOI":"10.1093\/bioinformatics\/btu048","article-title":"Cas-OFFinder: A fast and versatile algorithm that searches for potential off-target sites of Cas9 RNA-guided endonucleases","volume":"30","author":"Bae","year":"2014","journal-title":"Bioinformatics"},{"key":"2023092913413966900_bib5","doi-asserted-by":"publisher","DOI":"10.1136\/jitc-2020-000845","article-title":"41BB-based and CD28-based CD123-redirected T-cells ablate human normal hematopoiesis in vivo","volume":"8","author":"Baroni","year":"2020","journal-title":"J. Immunother. Cancer"},{"key":"2023092913413966900_bib6","doi-asserted-by":"publisher","first-page":"11978","DOI":"10.1073\/pnas.1819992116","article-title":"Gene-edited stem cells enable CD33-directed immune therapy for myeloid malignancies","volume":"116","author":"Borot","year":"2019","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"2023092913413966900_bib7","doi-asserted-by":"publisher","first-page":"4817","DOI":"10.1182\/blood-2011-04-348540","article-title":"Safety and persistence of adoptively transferred autologous CD19-targeted T cells in patients with relapsed or chemotherapy refractory B-cell leukemias","volume":"118","author":"Brentjens","year":"2011","journal-title":"Blood"},{"key":"2023092913413966900_bib8","doi-asserted-by":"publisher","first-page":"410","DOI":"10.1016\/j.celrep.2014.06.038","article-title":"Dual mechanism of interleukin-3 receptor blockade by an anti-cancer antibody","volume":"8","author":"Broughton","year":"2014","journal-title":"Cell Rep."},{"key":"2023092913413966900_bib9","doi-asserted-by":"publisher","first-page":"386","DOI":"10.1038\/s41467-017-02633-7","article-title":"A dual role for the N-terminal domain of the IL-3 receptor in cell signalling","volume":"9","author":"Broughton","year":"2018","journal-title":"Nat. Commun."},{"key":"2023092913413966900_bib10","doi-asserted-by":"publisher","first-page":"2213","DOI":"10.1038\/leu.2014.128","article-title":"Targeting of acute myeloid leukemia in vitro and in vivo with an anti-CD123 mAb engineered for optimal ADCC","volume":"28","author":"Busfield","year":"2014","journal-title":"Leukemia"},{"key":"2023092913413966900_bib11","doi-asserted-by":"publisher","first-page":"2789","DOI":"10.1016\/j.cell.2022.05.029","article-title":"Designing antibodies as therapeutics","volume":"185","author":"Carter","year":"2022","journal-title":"Cell"},{"key":"2023092913413966900_bib12","doi-asserted-by":"publisher","first-page":"440","DOI":"10.1089\/crispr.2020.0053","article-title":"Evaluation of homology-independent CRISPR-Cas9 off-target assessment methods","volume":"3","author":"Chaudhari","year":"2020","journal-title":"CRISPR J."},{"key":"2023092913413966900_bib13","doi-asserted-by":"publisher","first-page":"289ra82","DOI":"10.1126\/scitranslmed.aaa5693","article-title":"A CD3xCD123 bispecific DART for redirecting host T cells to myelogenous leukemia: Preclinical activity and safety in nonhuman primates","volume":"7","author":"Chichili","year":"2015","journal-title":"Sci. Transl. Med."},{"key":"2023092913413966900_bib14","doi-asserted-by":"publisher","first-page":"899","DOI":"10.1056\/NEJMoa2300709","article-title":"Base-Edited CAR7 T Cells for Relapsed T-Cell Acute Lymphoblastic Leukemia","volume":"389","author":"Chiesa","year":"2023","journal-title":"N. Engl. J. Med."},{"key":"2023092913413966900_bib15","doi-asserted-by":"publisher","first-page":"224","DOI":"10.1038\/s41587-019-0032-3","article-title":"CRISPResso2 provides accurate and rapid genome editing sequence analysis","volume":"37","author":"Clement","year":"2019","journal-title":"Nat. Biotechnol."},{"key":"2023092913413966900_bib16","doi-asserted-by":"publisher","first-page":"4724","DOI":"10.1038\/s41467-022-32233-z","article-title":"Ultra-deep sequencing validates safety of CRISPR\/Cas9 genome editing in human hematopoietic stem and progenitor cells","volume":"13","author":"Cromer","year":"2022","journal-title":"Nat. Commun."},{"key":"2023092913413966900_bib17","doi-asserted-by":"publisher","first-page":"1296","DOI":"10.1126\/science.1149726","article-title":"Efficient transplantation via antibody-based clearance of hematopoietic stem cell niches","volume":"318","author":"Czechowicz","year":"2007","journal-title":"Science"},{"key":"2023092913413966900_bib18","doi-asserted-by":"publisher","first-page":"617","DOI":"10.1038\/s41467-018-08201-x","article-title":"Selective hematopoietic stem cell ablation using CD117-antibody-drug-conjugates enables safe and effective transplantation with immunity preservation","volume":"10","author":"Czechowicz","year":"2019","journal-title":"Nat. Commun."},{"key":"2023092913413966900_bib19","doi-asserted-by":"publisher","first-page":"384","DOI":"10.1038\/nature20134","article-title":"CRISPR\/Cas9 \u03b2-globin gene targeting in human haematopoietic stem cells","volume":"539","author":"Dever","year":"2016","journal-title":"Nature"},{"key":"2023092913413966900_bib20","doi-asserted-by":"publisher","first-page":"360ra134","DOI":"10.1126\/scitranslmed.aaf9336","article-title":"Selection-free genome editing of the sickle mutation in human adult hematopoietic stem\/progenitor cells","volume":"8","author":"DeWitt","year":"2016","journal-title":"Sci. Transl. Med."},{"key":"2023092913413966900_bib21","doi-asserted-by":"publisher","first-page":"333","DOI":"10.1093\/bioinformatics\/btm604","article-title":"Mutual information without the influence of phylogeny or entropy dramatically improves residue contact prediction","volume":"24","author":"Dunn","year":"2008","journal-title":"Bioinformatics"},{"key":"2023092913413966900_bib22","doi-asserted-by":"publisher","first-page":"012707","DOI":"10.1103\/PhysRevE.87.012707","article-title":"Improved contact prediction in proteins: Using pseudolikelihoods to infer potts models","volume":"87","author":"Ekeberg","year":"2013","journal-title":"Phys. Rev. E Stat. Nonlin. Soft Matter Phys."},{"key":"2023092913413966900_bib23","doi-asserted-by":"publisher","first-page":"1282","DOI":"10.1172\/JCI113727","article-title":"Human recombinant granulocyte-macrophage colony stimulating factor and interleukin 3 have overlapping but distinct hematopoietic activities","volume":"82","author":"Emerson","year":"1988","journal-title":"J. Clin. Invest."},{"key":"2023092913413966900_bib24","doi-asserted-by":"publisher","first-page":"616","DOI":"10.1038\/s41551-023-01026-0","article-title":"Ex vivo prime editing of patient haematopoietic stem cells rescues sickle-cell disease phenotypes after engraftment in mice","volume":"7","author":"Everette","year":"2023","journal-title":"Nat. Biomed. Eng."},{"key":"2023092913413966900_bib25","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1038\/nature21405","article-title":"Targeting a CAR to the TRAC locus with CRISPR\/Cas9 enhances tumour rejection","volume":"543","author":"Eyquem","year":"2017","journal-title":"Nature"},{"key":"2023092913413966900_bib26","doi-asserted-by":"publisher","first-page":"678","DOI":"10.1038\/s41591-022-01765-8","article-title":"Engineered cellular immunotherapies in cancer and beyond","volume":"28","author":"Finck","year":"2022","journal-title":"Nat. Med."},{"key":"2023092913413966900_bib27","doi-asserted-by":"publisher","first-page":"2343","DOI":"10.1182\/blood-2013-09-529537","article-title":"Preclinical targeting of human acute myeloid leukemia and myeloablation using chimeric antigen receptor-modified T cells","volume":"123","author":"Gill","year":"2014","journal-title":"Blood"},{"key":"2023092913413966900_bib28","doi-asserted-by":"publisher","first-page":"2151","DOI":"10.1002\/eji.202049064","article-title":"CAR T cells: Building on the CD19 paradigm","volume":"51","author":"Globerson Levin","year":"2021","journal-title":"Eur. J. Immunol."},{"key":"2023092913413966900_bib29","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1038\/s41375-018-0180-3","article-title":"Coexpression profile of leukemic stem cell markers for combinatorial targeted therapy in AML","volume":"33","author":"Haubner","year":"2019","journal-title":"Leukemia"},{"key":"2023092913413966900_bib30","doi-asserted-by":"publisher","first-page":"128","DOI":"10.1038\/nbt.3769","article-title":"Mutation effects predicted from sequence co-variation","volume":"35","author":"Hopf","year":"2017","journal-title":"Nat. Biotechnol."},{"key":"2023092913413966900_bib31","doi-asserted-by":"publisher","first-page":"1582","DOI":"10.1093\/bioinformatics\/bty862","article-title":"The EVcouplings python framework for coevolutionary sequence analysis","volume":"35","author":"Hopf","year":"2019","journal-title":"Bioinformatics"},{"key":"2023092913413966900_bib32","doi-asserted-by":"publisher","first-page":"762","DOI":"10.1038\/s41375-018-0277-8","article-title":"Engineering resistance to CD33-targeted immunotherapy in normal hematopoiesis by CRISPR\/Cas9-deletion of CD33 exon 2","volume":"33","author":"Humbert","year":"2019","journal-title":"Leukemia"},{"key":"2023092913413966900_bib33","doi-asserted-by":"publisher","first-page":"106178","DOI":"10.1016\/j.leukres.2019.106178","article-title":"Development of a novel fully-human anti-CD123 antibody to target acute myeloid leukemia","volume":"84","author":"Hutmacher","year":"2019","journal-title":"Leuk. Res."},{"key":"2023092913413966900_bib34","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1016\/j.ccell.2021.12.011","article-title":"A roadmap for driving CAR T cells toward the oncogenic immunopeptidome","volume":"40","author":"Irving","year":"2022","journal-title":"Cancer Cell"},{"key":"2023092913413966900_bib35","doi-asserted-by":"publisher","first-page":"1777","DOI":"10.1038\/sj.leu.2401903","article-title":"The interleukin-3 receptor alpha chain is a unique marker for human acute myelogenous leukemia stem cells","volume":"14","author":"Jordan","year":"2000","journal-title":"Leukemia"},{"key":"2023092913413966900_bib36","doi-asserted-by":"publisher","first-page":"1361","DOI":"10.1126\/science.aar6711","article-title":"CAR T cell immunotherapy for human cancer","volume":"359","author":"June","year":"2018","journal-title":"Science"},{"key":"2023092913413966900_bib37","doi-asserted-by":"publisher","first-page":"95ra73","DOI":"10.1126\/scitranslmed.3002842","article-title":"T cells with chimeric antigen receptors have potent antitumor effects and can establish memory in patients with advanced leukemia","volume":"3","author":"Kalos","year":"2011","journal-title":"Sci. Transl. Med."},{"key":"2023092913413966900_bib38","doi-asserted-by":"publisher","first-page":"1439","DOI":"10.1016\/j.cell.2018.05.013","article-title":"Genetic inactivation of CD33 in hematopoietic stem cells to enable CAR T cell immunotherapy for acute myeloid leukemia","volume":"173","author":"Kim","year":"2018","journal-title":"Cell"},{"key":"2023092913413966900_bib39","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1186\/s40959-021-00122-x","article-title":"Acute cardiotoxicity after initiation of the novel tyrosine kinase inhibitor gilteritinib for acute myeloid leukemia","volume":"7","author":"Kim","year":"2021","journal-title":"Cardiooncology"},{"key":"2023092913413966900_bib40","doi-asserted-by":"publisher","first-page":"323","DOI":"10.1002\/jcp.1041400219","article-title":"Establishment and characterization of a unique human cell line that proliferates dependently on GM-CSF, IL-3, or erythropoietin","volume":"140","author":"Kitamura","year":"1989","journal-title":"J. Cell. Physiol."},{"key":"2023092913413966900_bib41","doi-asserted-by":"publisher","first-page":"4099","DOI":"10.1182\/blood-2010-04-281931","article-title":"Eradication of B-lineage cells and regression of lymphoma in a patient treated with autologous T cells genetically engineered to recognize CD19","volume":"116","author":"Kochenderfer","year":"2010","journal-title":"Blood"},{"key":"2023092913413966900_bib42","doi-asserted-by":"publisher","first-page":"2489","DOI":"10.4049\/jimmunol.1701121","article-title":"Highly efficient and versatile plasmid-based gene editing in primary T cells","volume":"200","author":"Kornete","year":"2018","journal-title":"J. Immunol."},{"key":"2023092913413966900_bib43","doi-asserted-by":"publisher","first-page":"848","DOI":"10.1182\/bloodadvances.2018017517","article-title":"A CD123-targeting antibody-drug conjugate, IMGN632, designed to eradicate AML while sparing normal bone marrow cells","volume":"2","author":"Kovtun","year":"2018","journal-title":"Blood Adv."},{"key":"2023092913413966900_bib44","doi-asserted-by":"publisher","first-page":"765","DOI":"10.1038\/s41375-023-01835-x","article-title":"Mitochondrial fusion is a therapeutic vulnerability of acute myeloid leukemia","volume":"37","author":"Larrue","year":"2023","journal-title":"Leukemia"},{"key":"2023092913413966900_bib45","doi-asserted-by":"publisher","first-page":"379","DOI":"10.1016\/0022-2836(71)90324-X","article-title":"The interpretation of protein structures: Estimation of static accessibility","volume":"55","author":"Lee","year":"1971","journal-title":"J. Mol. Biol."},{"key":"2023092913413966900_bib46","doi-asserted-by":"publisher","first-page":"517","DOI":"10.1016\/S0140-6736(14)61403-3","article-title":"T cells expressing CD19 chimeric antigen receptors for acute lymphoblastic leukaemia in children and young adults: A phase 1 dose-escalation trial","volume":"385","author":"Lee","year":"2015","journal-title":"Lancet"},{"key":"2023092913413966900_bib47","doi-asserted-by":"publisher","first-page":"616","DOI":"10.1038\/s41467-018-08202-w","article-title":"Hematopoietic chimerism and donor-specific skin allograft tolerance after non-genotoxic CD117 antibody-drug-conjugate conditioning in MHC-mismatched allotransplantation","volume":"10","author":"Li","year":"2019","journal-title":"Nat. Commun."},{"key":"2023092913413966900_bib48","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1016\/j.exphem.2003.11.010","article-title":"Diphtheria toxin fused to variant interleukin-3 provides enhanced binding to the interleukin-3 receptor and more potent leukemia cell cytotoxicity","volume":"32","author":"Liu","year":"2004","journal-title":"Exp. Hematol."},{"key":"2023092913413966900_bib49","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1038\/s41586-019-1805-z","article-title":"c-Jun overexpression in CAR T cells induces exhaustion resistance","volume":"576","author":"Lynn","year":"2019","journal-title":"Nature"},{"key":"2023092913413966900_bib50","doi-asserted-by":"publisher","first-page":"1219","DOI":"10.1158\/2159-8290.CD-18-0442","article-title":"Tumor antigen escape from CAR T-cell therapy","volume":"8","author":"Majzner","year":"2018","journal-title":"Cancer Discov."},{"key":"2023092913413966900_bib51","doi-asserted-by":"publisher","first-page":"1341","DOI":"10.1038\/s41591-019-0564-6","article-title":"Clinical lessons learned from the first leg of the CAR T cell journey","volume":"25","author":"Majzner","year":"2019","journal-title":"Nat. Med."},{"key":"2023092913413966900_bib52","doi-asserted-by":"publisher","first-page":"4064","DOI":"10.1182\/blood-2013-12-543801","article-title":"Integrated genetic approaches identify the molecular mechanisms of Sox4 in early B-cell development: Intricate roles for RAG1\/2 and CK1\u03b5","volume":"123","author":"Mallampati","year":"2014","journal-title":"Blood"},{"key":"2023092913413966900_bib53","doi-asserted-by":"publisher","first-page":"1507","DOI":"10.1056\/NEJMoa1407222","article-title":"Chimeric antigen receptor T cells for sustained remissions in leukemia","volume":"371","author":"Maude","year":"2014","journal-title":"N. Engl. J. Med."},{"key":"2023092913413966900_bib54","doi-asserted-by":"publisher","first-page":"503","DOI":"10.1038\/s41586-021-04390-6","article-title":"Decade-long leukaemia remissions with persistence of CD4+ CAR T cells","volume":"602","author":"Melenhorst","year":"2022","journal-title":"Nature"},{"key":"2023092913413966900_bib55","doi-asserted-by":"publisher","first-page":"189","DOI":"10.12688\/f1000research.7931.1","article-title":"FreeSASA: An open source C library for solvent accessible surface area calculations","volume":"5","author":"Mitternacht","year":"2016","journal-title":"F1000 Res."},{"key":"2023092913413966900_bib56","doi-asserted-by":"publisher","first-page":"567","DOI":"10.1056\/NEJMc2107725","article-title":"CD19-targeted CAR T cells in refractory systemic lupus erythematosus","volume":"385","author":"Mougiakakos","year":"2021","journal-title":"N. Engl. J. Med."},{"key":"2023092913413966900_bib57","doi-asserted-by":"publisher","first-page":"2688","DOI":"10.1038\/s41375-020-0818-9","article-title":"Anti-human CD117 CAR T-cells efficiently eliminate healthy and malignant CD117-expressing hematopoietic cells","volume":"34","author":"Myburgh","year":"2020","journal-title":"Leukemia"},{"key":"2023092913413966900_bib58","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1038\/s41587-019-0325-6","article-title":"Polymer-stabilized Cas9 nanoparticles and modified repair templates increase genome editing efficiency","volume":"38","author":"Nguyen","year":"2020","journal-title":"Nat. Biotechnol."},{"key":"2023092913413966900_bib59","doi-asserted-by":"publisher","first-page":"457","DOI":"10.3324\/haematol.2022.281456","article-title":"Potent preclinical activity of FLT3-directed chimeric antigen receptor T-cell immunotherapy against FLT3- mutant acute myeloid leukemia and KMT2A-rearranged acute lymphoblastic leukemia","volume":"108","author":"Niswander","year":"2023","journal-title":"Haematologica"},{"key":"2023092913413966900_bib60","doi-asserted-by":"publisher","first-page":"738","DOI":"10.1038\/nbt.3584","article-title":"Non-genotoxic conditioning for hematopoietic stem cell transplantation using a hematopoietic-cell-specific internalizing immunotoxin","volume":"34","author":"Palchaudhuri","year":"2016","journal-title":"Nat. Biotechnol."},{"key":"2023092913413966900_bib61","doi-asserted-by":"publisher","first-page":"4262","DOI":"10.1172\/JCI84813","article-title":"Targeted antibody-mediated depletion of murine CD19 CAR T cells permanently reverses B cell aplasia","volume":"126","author":"Paszkiewicz","year":"2016","journal-title":"J. Clin. Invest."},{"key":"2023092913413966900_bib62","doi-asserted-by":"publisher","first-page":"506","DOI":"10.1016\/j.ccell.2017.09.004","article-title":"Integrating proteomics and transcriptomics for systematic combinatorial chimeric antigen receptor therapy of AML","volume":"32","author":"Perna","year":"2017","journal-title":"Cancer Cell"},{"key":"2023092913413966900_bib63","doi-asserted-by":"publisher","first-page":"1011","DOI":"10.1016\/j.jacc.2013.08.1647","article-title":"FLT3 activation improves post-myocardial infarction remodeling involving a cytoprotective effect on cardiomyocytes","volume":"63","author":"Pfister","year":"2014","journal-title":"J. Am. Coll. Cardiol."},{"key":"2023092913413966900_bib64","doi-asserted-by":"publisher","first-page":"725","DOI":"10.1056\/NEJMoa1103849","article-title":"Chimeric antigen receptor-modified T cells in chronic lymphoid leukemia","volume":"365","author":"Porter","year":"2011","journal-title":"N. Engl. J. Med."},{"key":"2023092913413966900_bib65","doi-asserted-by":"publisher","first-page":"1130736","DOI":"10.3389\/fgeed.2023.1130736","article-title":"T-CAST: An optimized CAST-seq pipeline for TALEN confirms superior safety and efficacy of obligate-heterodimeric scaffolds","volume":"5","author":"Rhiel","year":"2023","journal-title":"Front. Genome Ed."},{"key":"2023092913413966900_bib66","doi-asserted-by":"publisher","DOI":"10.1200\/jco.2010.28.15_suppl.e13012","article-title":"A phase I study of anti-CD123 monocional antibody (mAb) CSL360 targeting leukemia stem cells (LSC) in AML","volume":"28","author":"Roberts","year":"2010","journal-title":"J. Clin. Oncol."},{"key":"2023092913413966900_bib67","doi-asserted-by":"publisher","first-page":"728","DOI":"10.1016\/j.cell.2020.03.039","article-title":"Pooled knockin targeting for genome engineering of cellular immunotherapies","volume":"181","author":"Roth","year":"2020","journal-title":"Cell"},{"key":"2023092913413966900_bib68","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1038\/s41586-018-0326-5","article-title":"Reprogramming human T cell function and specificity with non-viral genome targeting","volume":"559","author":"Roth","year":"2018","journal-title":"Nature"},{"key":"2023092913413966900_bib69","doi-asserted-by":"publisher","first-page":"1720","DOI":"10.1158\/2159-8290.CD-22-0411","article-title":"C\/EBPa confers dependence to fatty acid anabolic pathways and vulnerability to lipid oxidative stress-induced ferroptosis in FLT3-mutant leukemia","volume":"13","author":"Sabatier","year":"2023","journal-title":"Cancer Discov."},{"key":"2023092913413966900_bib70","doi-asserted-by":"publisher","first-page":"41","DOI":"10.3390\/antib8030041","article-title":"Bispecific T-cell redirection versus chimeric antigen receptor (CAR)-T cells as approaches to kill cancer cells","volume":"8","author":"Strohl","year":"2019","journal-title":"Antibodies"},{"key":"2023092913413966900_bib71","doi-asserted-by":"publisher","first-page":"926","DOI":"10.1093\/bioinformatics\/btu739","article-title":"UniRef clusters: A comprehensive and scalable alternative for improving sequence similarity searches","volume":"31","author":"Suzek","year":"2015","journal-title":"Bioinformatics"},{"key":"2023092913413966900_bib72","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1016\/j.jim.2007.09.017","article-title":"Efficient generation of monoclonal antibodies from single human B cells by single cell RT-PCR and expression vector cloning","volume":"329","author":"Tiller","year":"2008","journal-title":"J. Immunol. Methods"},{"key":"2023092913413966900_bib73","doi-asserted-by":"publisher","first-page":"1136","DOI":"10.1016\/j.stem.2021.02.002","article-title":"Quantitative evaluation of chromosomal rearrangements in gene-edited human stem cells by CAST-Seq","volume":"28","author":"Turchiano","year":"2021","journal-title":"Cell Stem Cell"},{"key":"2023092913413966900_bib74","doi-asserted-by":"publisher","first-page":"875","DOI":"10.1016\/j.tibtech.2021.12.009","article-title":"Roadmap to affinity-tuned antibodies for enhanced chimeric antigen receptor T cell function and selectivity","volume":"40","author":"Vander Mause","year":"2022","journal-title":"Trends Biotechnol."},{"key":"2023092913413966900_bib75","doi-asserted-by":"publisher","first-page":"286","DOI":"10.1126\/science.aav9023","article-title":"Unbiased detection of CRISPR off-targets in vivo using DISCOVER-Seq","volume":"364","author":"Wienert","year":"2019","journal-title":"Science"},{"key":"2023092913413966900_bib76","doi-asserted-by":"publisher","first-page":"1212","DOI":"10.1038\/s41591-022-01819-x","article-title":"A cellular hierarchy framework for understanding heterogeneity and predicting drug response in acute myeloid leukemia","volume":"28","author":"Zeng","year":"2022","journal-title":"Nat. Med."}],"container-title":["Journal of Experimental Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/rupress.org\/jem\/article-pdf\/doi\/10.1084\/jem.20231235\/1918994\/jem_20231235.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/rupress.org\/jem\/article-pdf\/doi\/10.1084\/jem.20231235\/1918994\/jem_20231235.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,29]],"date-time":"2023-09-29T09:43:21Z","timestamp":1695980601000},"score":1,"resource":{"primary":{"URL":"https:\/\/rupress.org\/jem\/article\/220\/12\/e20231235\/276306\/Epitope-engineered-human-hematopoietic-stem-cells"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,9,29]]},"references-count":76,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2023,12,4]]}},"URL":"https:\/\/doi.org\/10.1084\/jem.20231235","relation":{"has-preprint":[{"id-type":"doi","id":"10.1101\/2023.07.11.547391","asserted-by":"object"}]},"ISSN":["0022-1007","1540-9538"],"issn-type":[{"value":"0022-1007","type":"print"},{"value":"1540-9538","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,9,29]]},"article-number":"e20231235"}}